REFERENCES
- Prichard B NC, Gillam P MS. Use of propranolol (Inderal) in treatment of hypertension. BMJ 1964; 2: 725–727
- The joint national committee on detection, evaluation, and treatment of high blood pressure. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNCV). Arch Intern Med 1993; 153: 154–183
- Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S, Maling T. The management of raised Blood pressure in New zealand: A discussion document. BMJ 1993; 307: 107–110
- Ogilvie R I, Burgess E D, Cusson J R, Feldman R D, Leiter L A, Myers M G. Report of Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. Can Med Assoc J 1993; 149: 575–584
- Black H R. The coronary artery disease paradox. The role of hyperinsulinemia and insulin resistance and implications for therapy. J Cardiovasc Pharmacol 1990; 15(suppl.5)s26–s38
- Samuelsson O, Hender T, Berglund G, Persson B, Andersson O K, Wilhelmsen L. Diabetes mellitus in treated hypertension: Incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in Primary Prevention Trial Goteborg, Sweden. J Hum Hypertens 1994; 8: 257–263
- Tötterman K., Groop L., Groop P. H., Kala R., Tolppanen E. M., Fyhrquist F. Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients. Eur. J. Clin. Pharmacol 1984; 26: 13–17
- Groop L, Tötterman K, Harno K, Gordin A. Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients. Acta Med Scand 1983; 213: 9–14
- Sawicki P T, Berger M. Effects of antihypertensive treatment with β-blockers on glucose metabolism. J Cardiovasc Pharmacol 1992; 20(suppl.11)s45–s48
- Janka H U, Ziegler A G, Disselhoff G, Mehnert H. Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin a1 in noninsulin-dependent diabetics. J Cardiovasc Pharmacol 1986; 8(suppl.11)s96–s99
- Ferrannini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–357
- Manalan A S, Besc H R, Watanabe A M. Characterization of (±) (3H)-carazolol binding to β-adrenoceptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung. Circ Res 1981; 49: 326–336
- Brodde O E, Schemuth R, Brinkmann M, Wang X L, Daul A, Borchard U. β-adrenoceptor antagonists (non-selective as well as β1-selective) with partial agonistic activity decrease β2-adrenoceptor density in human lymphocytes. Evidence for a β2-agonistic component of partial Agonistic activity. Naunyn-Schmiedeberg's Arch Pharmacol 1986; 333: 130–138
- Wellstein A, Palm D, Belz G G. Affinity and electivity of β-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol 1986; 8(suppl.11)s36–s40
- Andronico G, Piazza G, Mangano M T, Mule G, Carone M B, Cerasola G. Nifedipine vs. enalapril In treatment of hypertensive patients with glucose intolerance. J Cardiovasc Pharmacol 1991; 18(suppl.10)s52–s54
- Hedner T., Samuelsson O., Lindholm L. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists. J Internal Med 1991; 229(suppl.2)101–111
- Lind L, Berne C, Pollare T, Lithell H. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study. J Human Hypertens 1995; 9: 137–141
- Ramsay L E, Yeo W W, Jackson P R. Influence of diuretics, calcium antagonists, and α-blockers on insulin sensitivity and glucose tolerance in hypertensive patients. J Cardiovasc Pharmacol 1992; 20(Suppl.11)s49–s54
- Giordano M, Matsuda M, Sanders L, Canessa M L, DeFronzo R A. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and α-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 1995; 44: 665–671
- Vuorinen-Markkola H., Yki-Jarvinen H. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 1995; 44: 85–89
- Pringle T H, Riddell J G. The cardioselectivity of beta adrenoceptor antagonist. Pharmac Ther 1990; 45: 39–68
- Bethge H, Leopold G., Wagner G. Bisoprolol in angina pectoris. Cardiovasc Drug Reviews 1991; 9: 110–122
- Gillman M W, Kannel W B, Belanger A., D'Agostino R B. Influence of heart rate on mortality among persons with hypertension: the framingham study. Am Heart J 1993; 125: 1148–1154
- McAinsh J, Davis J M. Beta 1 selectivity, antihypertensive effect and the frequency of stroke. Acta Therapeutica 1992; 18: 373–419